Goldman Sachs’s Select Medical SEM Stock Holding History
Bought
Maintained
Sold
Other funds holding SEM
GCL
AA
DAM
PAMP
Goldman Sachs's SEM Position: Q2 2026 in Review
Goldman Sachs reduced its Select Medical (SEM) stake by 58% in Q2 2026, selling an estimated $19.9M and leaving 871,540 shares worth $14.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2948.
Goldman Sachs first reported a position in SEM in Q2 2013 and has held it in 53 quarters since. The position peaked at $80.5M in Q2 2021. 241 funds tracked by Wall St. Rank hold SEM as of Q2 2026.
- Goldman Sachs held 871,540 shares of Select Medical worth $14.4M as of Q2 2026.
- Goldman Sachs sold 1,210,343 Select Medical shares in Q2 2026, an estimated $19.9M.
- Select Medical made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #2948 holding.
- Goldman Sachs first reported a position in Select Medical in Q2 2013 and has held it in 53 quarters since.
- Goldman Sachs's Select Medical position peaked at $80.5M in Q2 2021.
- 241 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.
Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.